Chordia Therapeutics (TSE:190A) Total Inventories : 円0.00 Mil (As of Aug. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Total Inventories?

Chordia Therapeutics's total inventories for the quarter that ended in Aug. 2024 was 円0.00 Mil. Chordia Therapeutics's average total inventories from the quarter that ended in Aug. 2023 to the quarter that ended in Aug. 2024 was 円0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Chordia Therapeutics's Net-Net Working Capital per share for the quarter that ended in Aug. 2024 was 円57.01.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Chordia Therapeutics's Days Inventory for the three months ended in Aug. 2024 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Chordia Therapeutics Total Inventories Historical Data

The historical data trend for Chordia Therapeutics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Total Inventories Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Total Inventories

Chordia Therapeutics Quarterly Data
	Aug21	Aug22	Aug23	Aug24
Total Inventories	-	-	-	-

Chordia Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Chordia Therapeutics (TSE:190A) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Chordia Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Aug. 2024 is

	Net-Net Working Capital Per Share (Q: Aug. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(4329.624	+	0.75 * 0	+	0.5 * 0	-	471.073
-	0	-	0)	/	67.679
=	57.01

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Chordia Therapeutics's Days Inventory for the three months ended in Aug. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Aug. 2024 )	/	Cost of Goods Sold (Q: Aug. 2024 )	*	Days in Period
	=	0	/	1499.795	*	365 / 4
	=	0.00

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Chordia Therapeutics's Inventory Turnover for the quarter that ended in Aug. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Aug. 2024 )	/	Average Total Inventories (Q: Aug. 2024 )
	=	1499.795	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Chordia Therapeutics's Inventory to Revenue for the quarter that ended in Aug. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Aug. 2024 )	/	Revenue (Q: Aug. 2024 )
	=	0	/	0
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Chordia Therapeutics Total Inventories Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines